Search clinical trials for: schizophrenia, LY2140023, pomaglumetad methionil
Total 26 results
-
Eli Lilly and CompanyTerminatedSchizophreniaGermany, Spain, United States, Sweden, Austria, France, Poland, Puerto Rico, Romania, Brazil, Greece
-
Denovo Biopharma LLCTerminatedSchizophreniaUnited States, Mexico, Russian Federation, Puerto Rico, Ukraine
-
Denovo Biopharma LLCCompleted
-
Denovo Biopharma LLCCompleted
-
Denovo Biopharma LLCCompleted
-
NYU Langone HealthTerminatedPost-traumatic Stress Disorder
-
Denovo Biopharma LLCCompleted
-
Denovo Biopharma LLCWithdrawn
-
Denovo Biopharma LLCTerminated
-
Denovo Biopharma LLCCompletedSchizophreniaRussian Federation
-
Eli Lilly and CompanyCompletedHealthy SubjectsUnited Kingdom
-
New York State Psychiatric InstituteNational Institute of Mental Health (NIMH)Completed
-
Denovo Biopharma LLCCompletedSchizophreniaItaly, United States, Spain, Israel
-
Denovo Biopharma LLCCompleted
-
Denovo Biopharma LLCCompletedSchizophreniaUnited States, Mexico, Germany, Russian Federation
-
Denovo Biopharma LLCCompletedSchizophrenic DisordersUnited States
-
Eli Lilly and CompanyCompleted
-
Denovo Biopharma LLCTerminatedSchizophreniaGermany, Spain, United States, Belgium, France, Sweden, Austria, Poland, Puerto Rico, Romania
-
Denovo Biopharma LLCCompleted
-
Eli Lilly and CompanyCompleted
-
Eli Lilly and CompanyCompletedSchizophreniaGermany, Mexico, Austria, Croatia, Romania, Russian Federation, Argentina, Portugal, South Africa
-
Eli Lilly and CompanyTerminatedSchizophreniaUnited States, Puerto Rico, Russian Federation, Mexico, Taiwan, Japan, Korea, Republic of, Ukraine, Croatia
-
University of California, Los AngelesNational Institute on Drug Abuse (NIDA)Terminated
-
New York State Psychiatric InstituteNational Institute of Mental Health (NIMH)Completed
-
Ludwig-Maximilians - University of MunichHeinrich-Heine University, Duesseldorf; University of Cologne; RWTH Aachen University and other collaboratorsUnknown